Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class.

Waste not, want not: free money, moral hazard and value-based prescribing. Int J Clin Pract (2011) 0.75

Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis. Int J Clin Pract (2011) 2.85

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet (1998) 26.64

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet (1996) 4.61

Management of heart failure. I. Pharmacologic treatment. JAMA (1994) 4.07

"Atypical" depression following childbirth. Br J Psychiatry (1968) 3.32

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med (2000) 3.25

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04

Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation (1975) 2.77

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) J Am Coll Cardiol (1990) 2.70

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61

Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation (1977) 2.22

BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ (1992) 2.21

Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17

Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16

Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation (2000) 2.15

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13

A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man. N Engl J Med (1971) 2.05

Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res (1971) 2.05

The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03

Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01

Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99

Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation (1980) 1.88

Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction. Am J Med (1977) 1.77

Home blood pressure monitoring. Arch Intern Med (2000) 1.71

High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol (1989) 1.61

Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57

Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation (1973) 1.57

Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol (2001) 1.57

Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57

Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol (1999) 1.56

Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol (1996) 1.55

Digitalis Investigation Group (DIG) trial: a stimulus for further research. Am Heart J (1997) 1.53

Abusing old people. BMJ (1992) 1.53

Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51

Better functional status in American than Canadian patients with heart disease: an effect of medical care? J Am Coll Cardiol (1995) 1.50

Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49

The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med (1997) 1.49

Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48

Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45

Scintiphotographic evaluation of patients with suspected left ventricular aneurysm. Circulation (1974) 1.45

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44

Thallium-201 for myocardial imaging: appearance of the normal heart. J Nucl Med (1976) 1.43

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med (1988) 1.39

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. Am J Cardiol (1999) 1.39

A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol (1971) 1.37

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation (1989) 1.33

Intravenous nitroglycerin in acute myocardial infarction. Circulation (1975) 1.32

Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29

ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation (1990) 1.29

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28

Unstable angina pectoris: morbidity and mortality in 57 consecutive patients evaluated angiographically. Am J Cardiol (1973) 1.28

Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28

The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins (1980) 1.24

Regional myocardial blood flow in the dog studied with radioactive microspheres. Cardiovasc Res (1971) 1.23

Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation (1976) 1.23

Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23

Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22

Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation (1994) 1.21

Myxoma of the left atrium. Hemodynamic and phonocardiographic consequences of sudden tumor movement. Circulation (1967) 1.21

Evaluating quality of care for patients with heart failure. Circulation (2000) 1.21

Coronary hemodynamic effects of increasing ventricular rate in the unanesthetized dog. Circ Res (1968) 1.21

Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation (1977) 1.20

The 'dop' system around Stellenbosch--results of a farm survey. S Afr Med J (1998) 1.18

Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18

Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J (1991) 1.15

Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res (1970) 1.15

Are all angiotensin-converting enzyme inhibitors interchangeable? J Am Coll Cardiol (2001) 1.14

Effect of indomethacin on collateral blood flow and infarct size in the conscious dog. Circulation (1979) 1.14

A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction. Circulation (1983) 1.13

Left ventricular function in acute myocardial infarction evaluation by gated scintiphotography. Circulation (1974) 1.11

Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11

Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10

Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10

Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10

Reperfusion therapy of acute myocardial infarction. Prog Cardiovasc Dis (1988) 1.10

Hemodynamic and prognostic findings in patients with transmural and nontransmural infarction. Circulation (1975) 1.09

The extraction of thallium-201 by the myocardium. Circulation (1977) 1.09

Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08

Hypercontractile cardiac states simulating hypertrophic cardiomyopathy. Circulation (1977) 1.08

Right ventricular dysfunction detected by gated scintiphotography in patients with acute inferior myocardial infarction. Circulation (1975) 1.08

Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07

Myocardial imaging with thallium-201: a multicenter study in patients with angina pectoris or acute myocardial infarction. Am J Cardiol (1978) 1.06

Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation (1988) 1.06

A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation (1987) 1.06

The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase. Circ Res (1985) 1.05

Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03

The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03

Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation (1995) 1.03

Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am J Cardiol (2000) 1.02